APA

Basu S., . (20140106). Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy?. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chicago

Basu Sandip, . 20140106. Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy?. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Harvard

Basu S., . (20140106). Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy?. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

MLA

Basu Sandip, . Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy?. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 20140106.